요오드화 조영제 부작용: 성분별 발생 빈도 비교 = Incidence of adverse drug reaction among 6 iodinated contrast media

다국어 초록 (Multilingual Abstract)

Purpose: Contrast media is one of the most common cause of adverse drug reaction (ADR) in adult. However, there was little data reported about differences in ADR ratio and severity among iodinated contrast media (ICM).
Methods: Medical records of 627,049 patients who performed computed tomography scan using low-osmolar nonionic iodinated contrast media from January 2015 to December 2018 were retrospectively reviewed. A total of 6 ICMs including iomeprol, iohexol, iopromide, iobitridol, ioversol, and iopamidol were used in this period. The incidence of ADR was compared to their total usage and dosage between each contrast media.
Results: The incidence of ADR of iopromide (1.36%) and iomeprol (1.27%) was the highest when compared with the average incidence of 1% of 6 ICMs. Ioversol (0.67%), iohexol, and iobitridol (0.74%) had the lower incidence of ADR. The order of results adjusted by actual administered dosage, the use of premedication, and the prior exposure history of ICMs was similar. The fraction of moderate and severe ADR in overall ADR was slightly different, but not proportional to the incidence of ADR.
Conclusion: The incidence of ADR among 6 low-osmolar nonionic ICMs was significantly different when compared by the total number of usage and the total volume of dose. The incidence of ADR varied by nearly 2-fold depending on ICMs. Further study might need to explore the reason for the difference of incidence. (Allergy Asthma Respir Dis 2021;9:84-92)

참고문헌 (Reference)

1 장광천, "한국 아나필락시스의 진료" 대한 소아알레르기 호흡기학회 1 (1): 181-196, 2013

2 김선신, "일반인에서 컴퓨터 단층촬영에 사용되는 조영제 과민반응의 발생빈도와 임상양상" 대한천식알레르기학회 27 (27): 157-161, 2007

3 신명진, "요오드화 조영제 유해반응의 예방과 치료" 대한의사협회 55 (55): 779-790, 2012

4 조민경, "요오드화 조영제 과민반응에 대한 임상 대처 최신 지견" 대한 소아알레르기 호흡기학회 8 (8): 107-113, 2020

5 김영진, "대한심장혈관영상의학회 심장 CT 권고안" 대한영상의학회 65 (65): 303-315, 2011

6 Cochran ST, "Trends in adverse events after IV administration of contrast media" 176 : 1385-1388, 2001

7 Lenhard DC, "The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety" 47 : 503-510, 2012

8 Jost G, "The impact of the viscosity and osmolality of iodine contrast agents on renal elimination" 45 : 255-261, 2010

9 Bae YJ, "The effectiveness of automatic recommending system for premedication in reducing recurrent radiocontrast media hypersensitivity reactions" 8 : e66014-, 2013

10 Uppsala Monitoring Centre, "The WHO adverse reaction terminology (WHO-ART): terminology for coding clinical information in relation to drug therapy" Uppsala Monitoring Centre

11 Kim MH, "Surveillance of contrast-media-induced hypersensitivity reactions using signals from an electronic medical recording system" 108 : 167-171, 2012

12 Vogl TJ, "Safety of iobitridol in the general population and at-risk patients" 16 : 1288-1297, 2006

13 Lee SY, "Radiocontrast media hypersensitivity in the Asia Pacific region" 4 : 119-125, 2014

14 Lasser EC, "Pretreatment with corticosteroids to prevent adverse reactions to nonionic contrast media" 162 : 523-526, 1994

15 Brockow K, "Management of hypersensitivity reactions to iodinated contrast media" 60 : 150-158, 2005

16 Korean Society of Radiology, "Korean clinical practice guideline on adverse reactions of injectable iodinated contrast agent and gadolinium contrast agent for MRI"

17 Lee SY, "Incidence and risk factors of immediate hypersensitivity reactions associated with low-osmolar iodinated contrast media : a longitudinal study based on a real-time monitoring system" 29 : 444-450, 2019

18 Clement O, "Immediate hypersensitivity to contrast agents : the french 5-year CIRTACI study" 1 : 51-61, 2018

19 Kim EY, "Image quality and attenuation values of multidetector CT coronary angiography using high iodine-concentration contrast material: a comparison of the use of iopromide 370 and iomeprol 400" 51 : 982-989, 2010

20 Cha MJ, "Hypersensitivity reactions to iodinated contrast media : a multicenter study of 196 081 patients" 293 : 117-124, 2019

21 Wang CL, "Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions" 191 : 409-415, 2008

22 Yang MS, "Epidemiologic and clinical features of anaphylaxis in Korea" 100 : 31-36, 2008

23 Vahldiek JL, "Effect of different iodine concentrations on patient-reported discomfort in contrast-enhanced computed tomography : a prospective comparative trial" 192 : 945-951, 2020

24 An J, "Differences in adverse reactions among iodinated contrast media : analysis of the KAERS database" 7 : 2205-2211, 2019

25 Meth MJ, "Current understanding of contrast media reactions and implications for clinical management" 29 : 133-141, 2006

26 성종미, "Comparison of the Safety of Seven Iodinated Contrast Media" 대한의학회 28 (28): 1703-1710, 2013

27 Korean Society of Radiology, "CT examination and repeat CT examination guidelines"

28 Gomi T, "Are there any differences in acute adverse reactions among five low-osmolar non-ionic iodinated contrast media" 20 : 1631-1635, 2010

29 Lerondeau B, "Analysis of cross-reactivity among radiocontrast media in 97 hypersensitivity reactions" 137 : 633-635, 2016

30 Idee JM, "Allergy-like reactions to iodinated contrast agents. A critical analysis" 19 : 263-281, 2005

31 Katayama H, "Adverse reactions to ionic and nonionic contrast media. a report from the Japanese Committee on the Safety of Contrast Media" 175 : 621-628, 1990

32 American College of Radiology, "ACR manual on contrast media. Version 10.3" American College of Radiology

33 Wolf GL, "A prospective trial of ionic vs nonionic contrast agents in routine clinical practice : comparison of adverse effects" 152 : 939-944, 1989